NDC 24357-701-01 - Anecream
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24357-701
- Requested NDC
- 24357-701-01
- Package NDCs from labels
- 24357-701-30, 24357-701-15, 24357-701-05, 24357-701-07, 24357-701-06, 24357-701-01, 24357-701-50
- Manufacturer
- Focus Health Group
- Effective date
- 2025-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Anecream - Focus Health Group | Focus Health Group | 2025-01-15 | HUMAN OTC DRUG LABEL |
| Anecream 4% | REMEDYREPACK INC. | 2017-12-20 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24357-701-01 | Anecream | 2.5 g in 1 PACKET | CREAM | 2.5 | 13 | |
| 24357-701-05 | Anecream | 5 g in 1 TUBE | CREAM | 5 | 13 | |
| 24357-701-06 | Anecream | 5 in 1 CARTON | CREAM | 5 | 13 | |
| 24357-701-07 | Anecream | 5 in 1 CARTON | CREAM | 5 | 13 | |
| 24357-701-15 | Anecream | 15 g in 1 TUBE | CREAM | 15 | 13 | |
| 24357-701-15 | Anecream | 1 in 1 CARTON | CREAM | 1 | 13 | |
| 24357-701-30 | Anecream | 1 in 1 CARTON | CREAM | 1 | 13 | |
| 24357-701-30 | Anecream | 30 g in 1 TUBE | CREAM | 30 | 13 | |
| 24357-701-50 | Anecream | 50 in 1 CARTON | CREAM | 50 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24357-701-07 | EA - Each | 24357-701 | 6bf9f8b6-794a-4ca7-901d-4ffcb2ceec98 | 1 | 2012-07-24 |
| 24357-701-15 | GM - Gram | 24357-701 | b90de22f-c3c4-42b8-9da2-ba9fec674c4a | 1 | 2012-07-24 |
| 24357-701-30 | GM - Gram | 24357-701 | 9ce9ab87-2ce7-4039-857d-b97202adf4cd | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| lidocaine | LIDOCAINE | Asclemed USA, Inc. | 58c9afe4-dc36-4f71-8e76-8dff63dc35fb | 2023-03-27 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | a134c265-4fb6-4c78-b9cc-fae8f1fff1cf | 2023-03-15 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | 68bc320f-2871-45b9-815e-bb26081e8249 | 2023-03-02 | Warnings, Adverse reactions | 98PI200987 |
| Icy Hot Pro Dry | CAMPHOR, MENTHOL | Chattem, Inc. | 4de1bc29-d166-4599-9e75-5f841bf20967 | 2023-03-01 | Warnings | M017 |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Lidocaine | LIDOCAINE | Bryant Ranch Prepack | da9707e2-f830-45e2-a300-1f99cf3dd362 | 2023-02-20 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | QUAGEN PHARMACEUTICALS LLC | f8789807-cc0c-485c-aa98-1bdc39337deb | 2023-02-15 | Warnings, Adverse reactions | 98PI200987 |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 6DC9Q167V3 |
| Vitrexyl plus Iron | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ada43056-a3ce-e7de-e053-2a95a90aa046 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | WR1WPI7EW8 |
| Rehydrate | AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORATUM, ULMUS FULVA, GLYCYRRHIZA GLABRA, SILICEA, PUERARIA LOBATA, CARLSBAD AQUA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, GERMANIUM SESQUIOXIDE, HYDROGEN, OXYGEN, WIESBADEN | ParaDocs All Natural, Inc. | 648fab10-c46b-420f-a42c-6642009d83fb | 2023-01-10 | Warnings | 059QF0KO0R |
| LIDODERM | LIDOCAINE PATCH 5% | TPU Pharma, Inc. | db0092f5-02a0-4076-ac32-969f075a6ab1 | 2022-12-02 | Warnings, Adverse reactions | 98PI200987 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.